Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial

Email this article to a friend

Samuel T Henderson^*, Janet L Vogel, Linda J Barr, Fiona Garvin, Julie J Jones and Lauren C Costantini

Nutrition & Metabolism 2009, 6:31 doi:10.1186/1743-7075-6-31